GLP-1 NEWS ROUNDUP: SAFETY, PIPELINE, PRICING & POLICY
There has been a lot of noise lately around GLP-1 medications - everything from federal indictments involving overseas chemical companies, to new triple-agonist drugs in development, to compounding crackdowns, pricing controversies, and...